Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672438 · ClinicalTrials.gov registry record · NA
Heritability of Opioid Effects: A Twin Study
A NA study, sponsored by Martin Angst.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT00672438 is a NA study that has completed, run by Martin Angst. The registered enrollment target is 242 participants.
The verdict
NCT00672438, a NA study, has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
Proposed twin study will test to what degree inter-individual differences in pain sensitivity and amount of pain relief in response to opioid therapy are inherited or alternatively, are due to environmental factors. This knowledge is important to guide future studies trying to explain such inter-individual differences. For example, finding that differences are largely due to environmental factors would discourage genomic studies and emphasize epidemiological studies.
Interventions
- DRUG Alfentanil
- OTHER Saline placebo infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00672438
The ClinicalTrials.gov registry entry for NCT00672438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Martin Angst, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alfentanil is the first listed.
NCT00672438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00672438 about?
NCT00672438 is a clinical study titled "Heritability of Opioid Effects: A Twin Study". Proposed twin study will test to what degree inter-individual differences in pain sensitivity and amount of pain relief in response to opioid therapy are inherited or alternatively, are due to environmental factors. This knowledge is important to guide future studies trying to explain such inter-ind...
What is the current status of trial NCT00672438?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2008-05. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00672438?
The interventions under investigation include: Alfentanil (DRUG), Saline placebo infusion (OTHER).
Who is sponsoring clinical trial NCT00672438?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.